Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116,587Revenue $M45,912Net Margin (%)7.6Altman Z-Score2.0
Enterprise Value $M132,382EPS $4.5Operating Margin %9.8Piotroski F-Score6
P/E(ttm)31.5Beneish M-Score-2.5Pre-tax Margin (%)9.8Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %5.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %3.3Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow26.0y-y EBITDA Growth Rate %-0.9ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.7PEG10.1ROE % (ttm)16.1Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M827ROIC % (ttm)10.0Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 141.05-3%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 141.052%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 141.054%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 141.0532%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 141.0582%Reduce 3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 141.0583%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 141.05135%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 141.05111%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 141.05167%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 141.05167%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 141.05168%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
    savings Apr 22 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
    Mallinckrodt Acquired San Diego Pharma and Much More Mar 21 2014 

    More From Other Websites
    Design students discover new creative possibilities with polycarbonate -- Creative material... Jul 03 2015
    Bayer Pearl introduces new polyurethane spray foam system in Middle East -- Excellent thermal... Jul 02 2015
    Bayer Files Hemophilia A Drug Marketing Application in Japan - Analyst Blog Jul 01 2015
    FDA OKs second test to see if Essure contraceptive is placed right Jul 01 2015
    Bayer shares climb on birth-control confirmation test Jul 01 2015
    Dr. Jacqueline Applegate to head Environmental Science at Bayer CropScience Jul 01 2015
    If Syngenta deal fizzles, here’s what a Monsanto bid for Bayer might look like Jun 30 2015
    Regeneron/Bayer's Eylea Gets Label Expansion in Japan - Analyst Blog Jun 29 2015
    Conference at Bayer CropScience in Monheim: -- A flood of research data offers opportunities for new... Jun 26 2015
    FDA Receives Complaints From Women About Sterilization Implant Jun 24 2015
    FDA panel to discuss safety of Bayer's contraceptive device Essure Jun 24 2015
    Monsanto Says Bayer Among Options If Syngenta Deal Fails Jun 23 2015
    Process innovation from Bayer MaterialScience: -- German state minister honors electricity-saving... Jun 19 2015
    Helping to spark interest of girls in science-related subjects: -- Bayer MaterialScience starts new... Jun 18 2015
    Bayer CropScience streamlines executive responsibilities Jun 17 2015
    13th International Conference on Malignant Lymphoma (ICML): -- Bayer to Present New Data on... Jun 17 2015
    Not intended for UK Media -- Bayer HealthCare and Johns Hopkins University Collaborate to Develop... Jun 16 2015
    Bayer to Present Latest Advances in Hemophilia Research at the ISTH 2015 Annual Congress in Toronto Jun 15 2015
    New Clinical Data Further Supporting the Positive Benefit Risk Profile of Bayer’s Xarelto® and... Jun 15 2015
    Bayer (BAYRY) Up on Deal to Sell Diabetes Care Business - Analyst Blog Jun 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK